- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02522390
The Nutrition Researcher Cohort 2014 Study (NRC250)
The Nutrition Researcher Cohort 2014 Study; New Standardized Self-quantification Methodologies Serving Both Research and Personal Health Maintenance
The primary objective of the planned Nutrition Research Cohort (NRC) n250 study is to develop and evaluate the open access Nutrition Researcher Cohort for gathering personal health data from nutrition researchers, including analytical methods, standards and operation procedures, data infrastructure, ethical and privacy aspects, and governance.
Besides, the study aims to exploit and analyse data on food, nutrient and bioactive compound intake and exposure, biomarkers for food, health and/or disease and health and/or disease related measurements to study the relation between nutrition, health and development of disease (on individual level).
In addition, data will be used to develop applications that visualise personal health risks based for example on (validated) recommendations and applications that predict individual health risks.
The study is designed as an open, one-group, exploratory cohort study. The total NRC cohort will be composed of about 250 life sciences employees and students from different, predominantly European, countries. This allows optimal involvement of participants in shaping all aspects of the cohort and the ownership of data. We aim to recruit about in total 20 male and female scientists per participating country.
Study Overview
Status
Intervention / Treatment
Detailed Description
The NRC n250 study is an open, one-group, open-ended cohort study, which will include participants from 10 different countries. The study will be coordinated by national contact points from each of the participating countries.
The NRC cohort study will start early 2015 and continue developing from that moment on. Recruitment will start immediately after approval of the study protocol in the country where it has been submitted. The Participant Information Form, which contains the complete research protocol as developed by the consortium partners, is available online via the NRC website. This way, potential participants can make an informed decision on whether or not they want to participate.
The NRC n250 study will provide a dataset from 250 individuals, including food intake, microbiome composition, oral glucose tolerance tests, a series of plasma (bio)chemistry outcomes, plasma and urine metabolome and DNA damage, together with anthropometrics and life style questionnaires.
Since the aim is to build up a powerful open access cohort, there is no end-date defined for this study. The collected data will be used for various analyses on food intake, biomarkers for food intake and/or health and/or disease, and health/disease related measurements.
The research questions that will be answered with this cohort are largely not known yet, since it is not known which data will become available. A NRC Scientific committee is established to judge whether or not the data in the cohort may be used for answering the proposed research questions. This Scientific committee consists of the principal investigators of the individual participating countries.
The Scientific committee is the entity that views all proposals (new studies, research questions) and decides whether or not it is in line with aim of NRC as well as ethics as well as scientifically robust. Approval for proposals can be obtained by positive response from a majority of the members (quality and ethics of proposals).
Institutions/companies that obtain data for a specific proposal, are only allowed to use the data for that specific purpose.
The NRC cohort also aims to serve as a platform to validate specific questionnaires (including food intake) or additional measurements (that are within scope of the NRC objectives). For offering an additional measurement or questionnaire to participants for health parameters that are already included in the protocols, also a request for approval should be filed to the scientific committee. The scientific committee will then decide (based on a positive response of the majority of the committee) if this measurement or questionnaire may be added. A request for data analysis with these new measures or questionnaires, other than validation purposes, has to be filed separately. If a request for approval is granted, participants still have the opportunity to opt out their data for use for this purpose.
For research questions that require additional measurements for health parameters that are not yet included in the protocol, amendments will be submitted to the Dutch Medical Research and Ethics Committee (MREC).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Graz, Austria, A-8036
- Medizinische Universität Graz
-
-
-
-
-
Leuven, Belgium
- University of Leuven (KU Leuven)
-
-
-
-
-
Prague, Czechia
- Charles University Prague
-
-
-
-
-
Copenhagen, Denmark
- University of Copenhagen
-
-
-
-
-
Kuopio, Finland, FI-70210
- University of Eastern Finland
-
-
-
-
-
Clermont, France
- INRA - L'Institut Nationel de la Recherche Agronomique
-
-
-
-
-
Dublin, Ireland
- University College Dublin
-
-
-
-
-
Rome, Italy, 00178
- CRA-NUT - Centro di Ricerca per gli Alimenti e la Nutrizione
-
-
-
-
Gelderland
-
Zeist, Gelderland, Netherlands
- TNO
-
-
-
-
-
Barcelona, Spain
- University of Barcelona
-
-
-
-
-
Berne, Switzerland
- Agroscope, Institute for Food Sciences
-
-
-
-
-
Newcastle, United Kingdom
- Newcastle University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Employees or students that are active in the field of nutrition and/or biology and/or health (e.g. epidemiologists, dieticians, nutrition students and researchers) that have a basic knowledge of nutrition and/or human biology and are thus able to form a scientific judgement on his/her own health data;
- good understanding of the English written language, since all communication is handled in English.
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Nutrition Researcher Cohort
This cohort study is an observational, one-group study.
The intervention consists of research activities that participants are asked to perform throughout the cohort, including the use of do-it-yourself devices, filling out online-questionnaires and sample collection with supplied kits for the analysis of various health parameters.
The frequency with which participants are asked to measure these health parameters varies, ranging from once to weekly.
|
Measurements are primarily based on "do-it-yourself" non-invasive or minimally invasive methods. Participants upload collected data to the Personal Health Portal. The measurements are divided into required and optional measurements. The required measurements mainly include routine methodology (e.g. weight, blood pressure, blood glucose); the latter also include methods under development that will be fine-tuned along the project. Which additional measures will be offered to participants is dependent on if funding or in-kind sponsoring is available. Participants will receive measurement kits for these analyses at-home and will be responsible for collection, labeling and shipment of samples themselves. After analysis the resulting data are uploaded to the user accounts.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body height
Time Frame: Baseline (week 1)
|
measured with do-it-yourself device in at-home setting
|
Baseline (week 1)
|
Body weight
Time Frame: Each week during entire cohort (five years in total)
|
measured with do-it-yourself device in at-home setting
|
Each week during entire cohort (five years in total)
|
Single Nucleotide Polymorphism (SNP) profile
Time Frame: Once during the cohort at baseline (a timepoint chosen by the participant in the first three months of the cohort)
|
No specific time of measurement has to be specified as genetic profile is not subject to change
|
Once during the cohort at baseline (a timepoint chosen by the participant in the first three months of the cohort)
|
Waist-to-hip ratio
Time Frame: Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
measured with waist circumference and hip circumference; measured with centimeter in at-home setting
|
Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
Blood pressure
Time Frame: Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
Diastolic and systolic blood pressure; measured with do-it-yourself device in at-home setting
|
Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
Resting heart rate
Time Frame: Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
measured after sitting still for at least 5 minutes; measured with do-it-yourself device in at-home setting
|
Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
fasting blood glucose
Time Frame: Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
measured after 8h fasting (only drinking water is allowed); measured with do-it-yourself device in at-home setting
|
Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort)
|
Blood cholesterol
Time Frame: quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
|
HDL, LDL, total cholesterol, triglycerides; measured with do-it-yourself device in at-home setting
|
quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
|
Food intake
Time Frame: quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
|
registration of food intake during two weekdays and one weekend day via an online application (e.g.
FatSecret)
|
quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
|
Physical activity tracker
Time Frame: quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
|
Registration of physical activity with a physical activity tracker (e.g.
FitBit) for at least one week continuously
|
quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
biomarker profile
Time Frame: once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
biomarkers for food intake (vitamins, fatty acids) and other blood biomarkers (cortisol, C Reactive protein (CRP), thyroid stimulating hormone (TSH), etc.)
|
once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
do-it-yourself oral glucose tolerance test
Time Frame: once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
insulin, glucose, c-peptide, HbA1c; including response profile after oral glucose tolerance test
|
once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
metabolomics
Time Frame: once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
|
metagenome
Time Frame: once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available
|
|
general health status
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
lifestyle (smoking, alcohol consumption, etc.)
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
general food intake
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a food frequency questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
quality of sleep
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
stress questionnaire
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
|
physical activity
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
wellness
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
cognition
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
quality of life
Time Frame: once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
via a questionnaire
|
once per year during entire cohort (Month 12, M24, M36, M48, M60)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
compliance with the study protocol
Time Frame: after one year (june 2016)
|
compliance will be determined for each of the included measurements and compared between participating countries
|
after one year (june 2016)
|
user experiences with participating in the cohort
Time Frame: after one year (june 2016)
|
as measured via a questionnaire
|
after one year (june 2016)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: André Boorsma, PhD, TNO
- Principal Investigator: Baukje de Roos, Newcastle University
- Principal Investigator: Giuditta Perozzi, CRA-NUT
- Principal Investigator: Lorraine Brennan, University College Dublin
- Principal Investigator: Christophe Matthys, University Leuven
- Principal Investigator: Irina Dobre, University of Copenhagen
- Principal Investigator: Miroslav Petr, Charles University Prague
- Principal Investigator: Andre Mazur, INRA - French National Institute for Agricultural Research
- Principal Investigator: Guy Vergères, PhD Dr, Agroscope Liebefeld-Posieux Research Station ALP
- Principal Investigator: Marjukka Kolehmainen, University of Eastern Finland
- Principal Investigator: Sandra Wallner, Med Uni Graz
- Principal Investigator: Cristina Andres-Lacueva, University of Barcelona
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P9616
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
An internal review board, consisting of Principal Investigators from all participating countries, will review all data requests.
A data request format is available that should be used for filing such a request. The format requires stating the research questions that should be answered with the requested data, type of data, populations requirements (exclusion criteria), data analysis and public disclosure.
All study participants have the ability to withdraw their data from use for answering specific research questions at any time.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biological Markers
-
Hospital AvicenneRoche Diagnostics; ProBayes; Biorance Laboratoires RéunisCompletedBiological Markers | Inappropriate PrescribingFrance
-
Cairo UniversityUnknown
-
Harvard School of Public Health (HSPH)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiet, Healthy | Biological Markers | Nutrition, Healthy | MetabolomicsUnited States
-
University Hospital, AkershusUniversity of Oslo; Helse Stavanger HFActive, not recruitingHeart Disease | Ventricular Arrhythmias | Implantable Defibrillator User | Biological MarkersNorway
-
Biomedical Development CorporationNational Heart, Lung, and Blood Institute (NHLBI); University of KentuckyUnknownGingivitis | Investigation of Biological Markers of InflammationUnited States
-
University of AarhusUnknownInflammatory Markers | Glucose Infusion | Bone MarkersDenmark
-
Paulista UniversityCompletedBiological Markers; Dental Implants; Cytokines; Triclosan; Toothpastes; Peri-Implantitis; Microbiology
-
Assistance Publique - Hôpitaux de ParisCompletedProstatic Neoplasms | Neoplasms, Hormone-Dependent | Survival Rate | Disease-Free Survival | Tumor Markers, BiologicalFrance
-
Johns Hopkins UniversityCompletedPancreatic Cancer | Neoplastic Cells, Circulating | Biological MarkersUnited States
-
Fundació EurecatCirce, S.L.Not yet recruiting
Clinical Trials on Research activities
-
University of Wisconsin, MadisonCompletedIntellectual Disability | Developmental Disability | Chronic Conditions, MultipleUnited States
-
National Taiwan University HospitalMinistry of Science and Technology, Taiwan; National Taiwan University; National...RecruitingCognitive TrainingTaiwan
-
Radboud University Medical CenterUniversitas TarumanagaraCompletedDepressive Symptoms | Well-beingIndonesia
-
Riphah International UniversityCompletedCardiac DiseasePakistan
-
Rio de Janeiro State UniversityOswaldo Cruz FoundationCompleted
-
Centre Hospitalier Universitaire de NiceCompletedPost-traumatic Stress DisorderFrance
-
University of Geneva, SwitzerlandNot yet recruitingUnilateral Spatial Neglect
-
National Taiwan University HospitalNational Taiwan Science Education Center(NTSEC)RecruitingCognitive Training | Subjective Cognitive DeclineTaiwan
-
The University of Hong KongThe Hong Kong Jockey Club Charities TrustRecruiting
-
T.C. ORDU ÜNİVERSİTESİCompleted